rs9943809

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001330260.2(SCN8A):​c.4281+13A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,603,488 control chromosomes in the GnomAD database, including 12,285 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). The gene SCN8A is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.090 ( 1020 hom., cov: 31)
Exomes 𝑓: 0.10 ( 11265 hom. )

Consequence

SCN8A
NM_001330260.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.432

Publications

11 publications found
Variant links:
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SCN8A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • developmental and epileptic encephalopathy, 13
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • cognitive impairment with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • seizures, benign familial infantile, 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile convulsions and choreoathetosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonus, familial, 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-51788761-A-G is Benign according to our data. Variant chr12-51788761-A-G is described in ClinVar as Benign. ClinVar VariationId is 139073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.351 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330260.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN8A
NM_001330260.2
MANE Select
c.4281+13A>G
intron
N/ANP_001317189.1Q9UQD0-2
SCN8A
NM_014191.4
MANE Plus Clinical
c.4281+13A>G
intron
N/ANP_055006.1Q9UQD0-1
SCN8A
NM_001177984.3
c.4158+13A>G
intron
N/ANP_001171455.1Q9UQD0-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN8A
ENST00000354534.11
TSL:1 MANE Plus Clinical
c.4281+13A>G
intron
N/AENSP00000346534.4Q9UQD0-1
SCN8A
ENST00000627620.5
TSL:5 MANE Select
c.4281+13A>G
intron
N/AENSP00000487583.2Q9UQD0-2
SCN8A
ENST00000599343.5
TSL:5
c.4314+13A>G
intron
N/AENSP00000476447.3Q9UQD0-3

Frequencies

GnomAD3 genomes
AF:
0.0902
AC:
13712
AN:
151976
Hom.:
1023
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0230
Gnomad AMI
AF:
0.0603
Gnomad AMR
AF:
0.0964
Gnomad ASJ
AF:
0.139
Gnomad EAS
AF:
0.364
Gnomad SAS
AF:
0.223
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0836
Gnomad OTH
AF:
0.0832
GnomAD2 exomes
AF:
0.133
AC:
32426
AN:
244588
AF XY:
0.135
show subpopulations
Gnomad AFR exome
AF:
0.0196
Gnomad AMR exome
AF:
0.141
Gnomad ASJ exome
AF:
0.130
Gnomad EAS exome
AF:
0.356
Gnomad FIN exome
AF:
0.170
Gnomad NFE exome
AF:
0.0846
Gnomad OTH exome
AF:
0.116
GnomAD4 exome
AF:
0.103
AC:
150049
AN:
1451394
Hom.:
11265
Cov.:
29
AF XY:
0.106
AC XY:
76578
AN XY:
721496
show subpopulations
African (AFR)
AF:
0.0203
AC:
677
AN:
33370
American (AMR)
AF:
0.135
AC:
5973
AN:
44170
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
3376
AN:
25862
East Asian (EAS)
AF:
0.426
AC:
16654
AN:
39052
South Asian (SAS)
AF:
0.207
AC:
17340
AN:
83744
European-Finnish (FIN)
AF:
0.158
AC:
8351
AN:
52904
Middle Eastern (MID)
AF:
0.0746
AC:
429
AN:
5750
European-Non Finnish (NFE)
AF:
0.0822
AC:
91006
AN:
1106574
Other (OTH)
AF:
0.104
AC:
6243
AN:
59968
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
5425
10850
16274
21699
27124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3698
7396
11094
14792
18490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0901
AC:
13701
AN:
152094
Hom.:
1020
Cov.:
31
AF XY:
0.0988
AC XY:
7345
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0229
AC:
951
AN:
41516
American (AMR)
AF:
0.0964
AC:
1474
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
481
AN:
3472
East Asian (EAS)
AF:
0.364
AC:
1878
AN:
5156
South Asian (SAS)
AF:
0.222
AC:
1062
AN:
4790
European-Finnish (FIN)
AF:
0.182
AC:
1929
AN:
10576
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0836
AC:
5680
AN:
67980
Other (OTH)
AF:
0.0823
AC:
174
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
569
1138
1708
2277
2846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0914
Hom.:
468
Bravo
AF:
0.0817
Asia WGS
AF:
0.251
AC:
871
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
7.2
DANN
Benign
0.49
PhyloP100
0.43
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9943809; hg19: chr12-52182545; COSMIC: COSV61982179; COSMIC: COSV61982179; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.